Validation of Updated Response Assessment Criteria for Glioblastoma (GBM) and Implications for Clinical Trial Reporting

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2016.06.753
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Validation and Clinical Implications of the IDSA/ATS Minor Criteria for Severe Community-Acquired Pneumonia

Thorax
PulmonaryRespiratory Medicine
2009English

Quantitative Magnetization Transfer in Monitoring Glioblastoma (GBM) Response to Therapy

Scientific Reports
Multidisciplinary
2018English

Microbiology Investigation Criteria for Reporting Objectively (MICRO): A Framework for the Reporting and Interpretation of Clinical Microbiology Data

Pathology
Forensic MedicinePathology
2020English

Phase I Clinical Trial of Temsirolimus and Perifosine for Recurrent Glioblastoma

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2020English

DSM-5 Criteria and Depression Severity: Implications for Clinical Practice

Frontiers in Psychiatry
PsychiatryMental Health
2018English

Criteria for Assessment of Cognitive Impairment in Clinical Trials

The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products
2018English

Glioblastoma Update: Molecular Biology, Diagnosis, Treatment, Response Assessment, and Translational Clinical Trials

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Clinical Implications of microRNAs in Human Glioblastoma

Frontiers in Oncology
Cancer ResearchOncology
2013English

Correction To: Updated Clinical Guidelines Experience Major Reporting Limitations

Implementation Science
EnvironmentalPublic HealthHealth InformaticsHealth PolicyMedicineOccupational Health
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy